Dr. Till on Data With Liso-Cel Vs Other Products Under Examination in MCL

SCCA's Brian Till, MD, spoke with OncLive about the safety and efficacy of lisocabtagene maraleucel compared with other treatments under exploration in people living with mantle cell lymphoma.

Watch the Video